Page last updated: 2024-11-05

trifluperidol and Akinetic-Rigid Variant of Huntington Disease

trifluperidol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tarighati, S1
a'Brook, MF1

Other Studies

1 other study available for trifluperidol and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Trifluperidol in Huntington's chorea.
    Lancet (London, England), 1968, Aug-24, Volume: 2, Issue:7565

    Topics: Aged; Antidepressive Agents; Butyrophenones; Fluorine; Humans; Huntington Disease; Middle Aged; Pipe

1968